The lectures given by Prof. Jean-Paul Clozel at the seminar " Biotechnology and society " are now available on video

The seminar will address three major challenges facing the biotech industry. Firstly, the difficulties of setting up a biotech company, particularly in Europe. Secondly, the relationship between biotech companies and universities, which are the main source of the major discoveries underpinning the development of most of these companies. Finally, the place of biotechnology in society will be considered from the angle of three specific aspects: the cost of biotechnology-derived drugs, the importance of new emerging diseases, particularly infectious diseases, and the widening gap between the United States and Europe in the development of biotechnology.

Jean-Paul Clozel, M.D.

A medical doctor, he turned to cardiology and became involved in research. Trained in several laboratories in Nancy, Paris, Montreal and San Francisco, he joined a private laboratory in 1985, where he contributed to major discoveries of new drugs. In 1997, together with three other researchers, he founded a company which, in less than ten years, has become the largest biotech company in Europe.